Mechanisms of botulinum toxin type A action on pain

I Matak, K Bölcskei, L Bach-Rojecky, Z Helyes - Toxins, 2019 - mdpi.com
Already a well-established treatment for different autonomic and movement disorders, the
use of botulinum toxin type A (BoNT/A) in pain conditions is now continuously expanding …

An update on the pharmacotherapeutic options for complex regional pain syndrome

G Iolascon, F Snichelotto, A Moretti - Expert Review of …, 2024 - Taylor & Francis
Introduction Complex regional pain syndrome (CRPS) is a rare and painful condition that
has a wide range of triggering factors, often traumatic, and can present various clinical …

Botulinum neurotoxin type A in the treatment of facial seborrhea and acne: evidence and a proposed mechanism

NK Rho, YC Gil - Toxins, 2021 - mdpi.com
Intradermal injection of botulinum neurotoxin is a frequently performed procedure in
aesthetic dermatology to improve facial skin tone, texture, fine wrinkles, and enlarged pores …

Novelty in inflammation and immunomodulation in migraine

C Cavestro, M Ferrero, S Mandrino… - Current …, 2019 - ingentaconnect.com
Background: Migraine is a diffuse and disabling disease. Its pathophysiology is complex and
involves both central and peripheral dysfunctions. Objective: This review will discuss the …

Pharmacotherapeutic options for complex regional pain syndrome

G Iolascon, A Moretti - Expert Opinion on Pharmacotherapy, 2019 - Taylor & Francis
Introduction: Complex regional pain syndromes (CRPS) are rare painful conditions
characterized by considerable variability in possible triggering factors, usually traumatic, and …

Comparative effectiveness of injection therapies for hemiplegic shoulder pain in stroke: a systematic review and network meta-analysis

YH Chiu, KV Chang, WT Wu, PC Hsu, L Özçakar - Pharmaceuticals, 2021 - mdpi.com
Hemiplegic shoulder pain (HSP) hampers post-stroke functional recovery and is not well
managed with conservative treatments. This systematic review aimed to examine the various …

Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects?

G De la Torre Canales, RL Poluha, VM Lora… - Clinical Oral …, 2019 - Springer
Objectives The objective of the study was to conduct a systematic review of literature
assessing botulinum toxin type A (BoNT-A) safety and adverse effects in the treatment of …

The effect of intraarticular botulinum toxin-A injection on symptoms of temporomandibular joint disorder

BC Sari, T Develi - Journal of Stomatology, Oral and Maxillofacial Surgery, 2022 - Elsevier
Introduction Application of arthrocentesis in temporomandibular joint disorders preferred
and suggested therapeutic treatment option in recent years. This study was designed to …

Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain

A Bagues, J Hu, I Alshanqiti, MK Chung - Pharmacology & Therapeutics, 2024 - Elsevier
Botulinum neurotoxins (BoNTs) are a family of neurotoxins produced by Clostridia and other
bacteria that induce botulism. BoNTs are internalized into nerve terminals at the site of …

[HTML][HTML] Prolonged Antipruritic Effect of Botulinum Toxin Type A on Cowhage-induced Itch: A Randomized, Single-blind, Placebo-controlled Trial

LA Nattkemper, A Vander Does, CM Stull… - Acta dermato …, 2023 - ncbi.nlm.nih.gov
Botulinum toxin type A (Botox®) is thought to have antipruritic effects through inhibition of
pruritic factors, including acetylcholine, substance P, and glutamate. The aim of this …